See up to 3 months of NKTR. The 7-day demo opens the 1M and 3M ranges and puts NKTR on your watchlist.
Start 7-day demoLatest NKTR insider trades
About NEKTAR THERAPEUTICS (NKTR)
NEKTAR THERAPEUTICS files with the SEC under CIK 0000906709 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
NKTR Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 2 | 604 | $43K |
| Grant or award | 12 | 103,700 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
NKTR insider transactions (Form 4)
2645 Form 4 filings on record, the earliest from Nov 20, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jonathan Zalevsky - Officer | Open-market sale | Common Stock | 485 | $30.10 | $15K | |
| Howard W. Robin - Officer | Open-market sale | Common Stock | 1,500 | $30.16 | $45K | |
| Mark Andrew Wilson - Officer | Open-market sale | Common Stock | 676 | $26.59 | $18K | |
| Mark Andrew Wilson - Officer | Grant or award | Stock Option | 21,666 | $0.00 | - | |
| Jonathan Zalevsky - Officer | Open-market sale | Common Stock | 725 | $26.59 | $19K | |
| Jonathan Zalevsky - Officer | Grant or award | Stock Option | 16,666 | $0.00 | - | |
| Howard W. Robin - Officer | Open-market sale | Common Stock | 1,573 | $26.59 | $42K | |
| Howard W. Robin - Officer | Grant or award | Stock Option | 86,666 | $0.00 | - | |
| Howard W. Robin - Officer | Open-market sale | Common Stock | 23,208 | $0.67 | $16K | |
| Mark Andrew Wilson - Officer | Open-market sale | Common Stock | 33,402 | $0.90 | $30K | |
| Mark Andrew Wilson - Officer | Open-market sale | Common Stock | 16,560 | $0.89 | $15K | |
| Jonathan Zalevsky - Officer | Open-market sale | Common Stock | 51,115 | $0.94 | $48K | |
| Howard W. Robin - Officer | Open-market sale | Common Stock | 46,995 | $1.01 | $47K | |
| Howard W. Robin - Officer | Open-market sale | Common Stock | 85,035 | $0.99 | $84K | |
| Mark Andrew Wilson - Officer | Grant or award | Common Stock | 165,938 | $0.00 | - | |
| Mark Andrew Wilson - Officer | Grant or award | Stock Option | 331,875 | $0.00 | - | |
| Mark Andrew Wilson - Officer | Grant or award | Stock Option | 325,000 | $0.00 | - | |
| Jonathan Zalevsky - Officer | Grant or award | Common Stock | 135,000 | $0.00 | - | |
| Jonathan Zalevsky - Officer | Grant or award | Stock Option | 270,000 | $0.00 | - | |
| Jonathan Zalevsky - Officer | Grant or award | Stock Option | 375,000 | $0.00 | - | |
| Howard W. Robin - Officer | Grant or award | Common Stock | 410,625 | $0.00 | - | |
| Howard W. Robin - Officer | Grant or award | Stock Option | 821,250 | $0.00 | - | |
| Howard W. Robin - Officer | Grant or award | Stock Option | 1,300,000 | $0.00 | - | |
| Mark Andrew Wilson - Officer | Open-market sale | Common Stock | 6,407 | $1.01 | $6K | |
| Jonathan Zalevsky - Officer | Open-market sale | Common Stock | 7,785 | $1.01 | $8K | |
| Howard W. Robin - Officer | Open-market sale | Common Stock | 16,278 | $1.01 | $16K |
Recent NKTR Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Zalevsky Jonathan | Officer | 186 | $13K | View on EDGAR | |
| ROBIN HOWARD W | Officer, Director | 418 | $30K |
NKTR insider trading FAQ
What is the latest insider trade for NKTR?
NEKTAR THERAPEUTICS (NKTR) had 9 insider filings in the last 90 days, with the most recent on 2026-09-26. The full record for NKTR runs to 45 Form 4 filings, the earliest from 2024-11-20. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying NKTR stock?
No insider purchases of NKTR were filed in the last 90 days.
How many insiders are selling NKTR stock?
2 insider sales of NKTR were filed in the last 90 days, totaling $43K.
Where can I see NKTR SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects NKTR Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Roy A. Whitfield view on EDGAR
- - R. Scott Greer view on EDGAR
- - Robert Chess view on EDGAR
- - Diana Brainard view on EDGAR
- - Jeffrey Robert Ajer view on EDGAR
- - Jonathan Zalevsky view on EDGAR
- - Howard W. Robin view on EDGAR
- - Jonathan Zalevsky view on EDGAR
- - Howard W. Robin view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where NKTR's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow NKTR with a 7-day demo
- NKTR on your watchlist
- Every NKTR Form 4 filing on record
- Up to 3 months of NKTR price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
